Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
8.05
+0.22 (2.81%)
Nov 28, 2025, 1:00 PM EST - Market closed
Journey Medical Analyst Ratings
Total Analysts
3
Consensus Rating
Strong Buy
Price Target
$12.67
Upside
+57.39%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $13 | Strong Buy | Initiates | $13 | +61.49% | Aug 25, 2025 |
| Lake Street | Lake Street | Strong Buy Maintains $9 → $13 | Strong Buy | Maintains | $9 → $13 | +61.49% | Aug 13, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $9 → $12 | Strong Buy | Maintains | $9 → $12 | +49.07% | Jul 30, 2025 |
| Lake Street | Lake Street | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +11.80% | Sep 6, 2024 |
| Roth MKM | Roth MKM | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +36.65% | Jun 28, 2024 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $8.5 | Strong Buy | Initiates | $8.5 | +5.59% | Feb 16, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | -25.47% | Sep 7, 2023 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $3 → $6 | Strong Buy | Maintains | $3 → $6 | -25.47% | Jul 12, 2023 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $6 → $3 | Strong Buy | Maintains | $6 → $3 | -62.73% | May 23, 2023 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | -25.47% | Mar 30, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $9 | Buy | Initiates | $9 | +11.80% | Feb 25, 2022 |
| Roth Capital | Roth Capital | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +86.34% | Dec 16, 2021 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $14 | Strong Buy | Initiates | $14 | +73.91% | Dec 7, 2021 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Feb 3, 2020 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $19 | Strong Buy → Hold | Downgrades | $19 | +132.92% | Jan 23, 2020 |
| Mizuho | Mizuho | Hold → Strong Buy Upgrades $17 → $14 | Hold → Strong Buy | Upgrades | $17 → $14 | +73.91% | Jun 6, 2019 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.